UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Osimertinib in Resected EGFR-Mutated Non–Small-Cell Lung Cancer

The New England journal of medicine, 2020-10, Vol.383 (18), p.1711-1723

2020

Volltextzugriff (PDF)

Mitofusins regulate lipid metabolism to mediate the development of lung fibrosis

Nature communications, 2019-07, Vol.10 (1), p.3390-17, Article 3390

2019

Volltextzugriff (PDF)

Mycobacterium abscessus complex infections in humans

Emerging infectious diseases, 2015-09, Vol.21 (9), p.1638-1646

2015

Volltextzugriff (PDF)

Clinical activity of afatinib in patients with advanced non-small-cell lung cancer harbouring uncommon EGFR mutations: a combined post-hoc analysis of LUX-Lung 2, LUX-Lung 3, and LUX-Lung 6

The lancet oncology, 2015-07, Vol.16 (7), p.830-838

2015

Volltextzugriff (PDF)

Emergence and Persistent Dominance of SARS-CoV-2 Omicron BA.2.3.7 Variant, Taiwan

Emerging infectious diseases, 2023-04, Vol.29 (4), p.792-796

2023

Volltextzugriff (PDF)

Effectiveness of Tyrosine Kinase Inhibitors on Uncommon Epidermal Growth Factor Receptor Mutations of Unknown Clinical Significance in Non―Small Cell Lung Cancer

Clinical cancer research, 2011-06, Vol.17 (11), p.3812-3821

2011

Volltextzugriff (PDF)

Metformin use mitigates the adverse prognostic effect of diabetes mellitus in chronic obstructive pulmonary disease

Respiratory research, 2019-04, Vol.20 (1), p.69-10, Article 69

2019

Volltextzugriff (PDF)

Clinical outcomes and secondary epidermal growth factor receptor (EGFR) T790M mutation among first‐line gefitinib, erlotinib and afatinib‐treated non‐small cell lung cancer patients with activating EGFR mutations

International journal of cancer, 2019-06, Vol.144 (11), p.2887-2896

2019

Volltextzugriff (PDF)

High Mortality in Severe Sepsis and Septic Shock Patients with Do-Not-Resuscitate Orders in East Asia

PloS one, 2016-07, Vol.11 (7), p.e0159501-e0159501

2016

Volltextzugriff (PDF)

Autophagy in fibroblasts induced by cigarette smoke extract promotes invasion in lung cancer cells

International journal of cancer, 2020-11, Vol.147 (9), p.2587-2596

2020

Volltextzugriff (PDF)

Postoperative Chemotherapy Use and Outcomes From ADAURA: Osimertinib as Adjuvant Therapy for Resected EGFR-Mutated NSCLC

Journal of thoracic oncology, 2022-03, Vol.17 (3), p.423-433

2022

Volltextzugriff (PDF)

Diabetes mellitus in patients with chronic obstructive pulmonary disease-The impact on mortality

PloS one, 2017-04, Vol.12 (4), p.e0175794-e0175794

2017

Volltextzugriff (PDF)

Identification of five driver gene mutations in patients with treatment-naïve lung adenocarcinoma in Taiwan

PloS one, 2015-03, Vol.10 (3), p.e0120852-e0120852

2015

Volltextzugriff (PDF)

In-hospital and one-year mortality and their predictors in patients hospitalized for first-ever chronic obstructive pulmonary disease exacerbations: a nationwide population-based study

PloS one, 2014-12, Vol.9 (12), p.e114866-e114866

2014

Volltextzugriff (PDF)

Sialylation and fucosylation of epidermal growth factor receptor suppress its dimerization and activation in lung cancer cells

Proceedings of the National Academy of Sciences - PNAS, 2011-07, Vol.108 (28), p.11332-11337

2011

Volltextzugriff (PDF)

Olmutinib in T790M‐positive non–small cell lung cancer after failure of first‐line epidermal growth factor receptor‐tyrosine kinase inhibitor therapy: A global, phase 2 study

Cancer, 2021-05, Vol.127 (9), p.1407-1416

2021

Volltextzugriff (PDF)

Real-world osimertinib pretreatment experience in patients with epidermal growth factor receptor T790M mutation-positive locally advanced or metastatic non-small cell lung cancer

PloS one, 2024-05, Vol.19 (5), p.e0303046

2024

Volltextzugriff (PDF)

Fucosyltransferase 8 as a functional regulator of nonsmall cell lung cancer

Proceedings of the National Academy of Sciences - PNAS, 2013-01, Vol.110 (2), p.630-635

2013

Volltextzugriff (PDF)

Monitoring of T790M in plasma ctDNA of advanced EGFR-mutant NSCLC patients on first- or second-generation tyrosine kinase inhibitors

BMC cancer, 2023-03, Vol.23 (1), p.234-234, Article 234

2023

Volltextzugriff (PDF)

The mechanism of acquired resistance to irreversible EGFR tyrosine kinase inhibitor-afatinib in lung adenocarcinoma patients

Oncotarget, 2016-03, Vol.7 (11), p.12404-12413

2016

Volltextzugriff (PDF)

Two‐month breathing‐based walking improves anxiety, depression, dyspnoea and quality of life in chronic obstructive pulmonary disease: A randomised controlled study

Journal of clinical nursing, 2019-10, Vol.28 (19-20), p.3632-3640

2019

Volltextzugriff (PDF)

Letter from Taiwan

Respirology (Carlton, Vic.), 2018-05, Vol.23 (5), p.535-537

Yu, Chong‐Jen

2018

Volltextzugriff (PDF)

Dispositional mindfulness, self‐compassion, and compassion from others as moderators between stress and depression in caregivers of patients with lung cancer

Psycho-oncology (Chichester, England), 2019-07, Vol.28 (7), p.1498-1505

2019

Volltextzugriff (PDF)

Trajectories of caregiver burden and related factors in family caregivers of patients with lung cancer

Psycho-oncology (Chichester, England), 2018-06, Vol.27 (6), p.1493-1500

2018

Volltextzugriff (PDF)

1 – 25 von 629

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(600)
Mit Volltextzugriff
(570)

Publikationsform

Artikel
(619)
Berichte
(10)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(7)

Menü

Weitere Dienste

Einstellungen

Osimertinib in Resected EGFR-Mutated Non–Small-Cell Lung Cancer

Mitofusins regulate lipid metabolism to mediate the development of lung fibrosis

Mycobacterium abscessus complex infections in humans

Clinical activity of afatinib in patients with advanced non-small-cell lung cancer harbouring uncommon EGFR mutations: a combined post-hoc analysis of LUX-Lung 2, LUX-Lung 3, and LUX-Lung 6

First-line ceritinib versus platinum-based chemotherapy in advanced ALK -rearranged non-small-cell lung cancer (ASCEND-4): a randomised, open-label, phase 3 study

Emergence and Persistent Dominance of SARS-CoV-2 Omicron BA.2.3.7 Variant, Taiwan

Effectiveness of Tyrosine Kinase Inhibitors on Uncommon Epidermal Growth Factor Receptor Mutations of Unknown Clinical Significance in Non―Small Cell Lung Cancer

Metformin use mitigates the adverse prognostic effect of diabetes mellitus in chronic obstructive pulmonary disease

Clinical outcomes and secondary epidermal growth factor receptor (EGFR) T790M mutation among first‐line gefitinib, erlotinib and afatinib‐treated non‐small cell lung cancer patients with activating EGFR mutations

High Mortality in Severe Sepsis and Septic Shock Patients with Do-Not-Resuscitate Orders in East Asia

Autophagy in fibroblasts induced by cigarette smoke extract promotes invasion in lung cancer cells

Postoperative Chemotherapy Use and Outcomes From ADAURA: Osimertinib as Adjuvant Therapy for Resected EGFR-Mutated NSCLC

Diabetes mellitus in patients with chronic obstructive pulmonary disease-The impact on mortality

Identification of five driver gene mutations in patients with treatment-naïve lung adenocarcinoma in Taiwan

In-hospital and one-year mortality and their predictors in patients hospitalized for first-ever chronic obstructive pulmonary disease exacerbations: a nationwide population-based study

Sialylation and fucosylation of epidermal growth factor receptor suppress its dimerization and activation in lung cancer cells

Olmutinib in T790M‐positive non–small cell lung cancer after failure of first‐line epidermal growth factor receptor‐tyrosine kinase inhibitor therapy: A global, phase 2 study

Real-world osimertinib pretreatment experience in patients with epidermal growth factor receptor T790M mutation-positive locally advanced or metastatic non-small cell lung cancer

Fucosyltransferase 8 as a functional regulator of nonsmall cell lung cancer

Monitoring of T790M in plasma ctDNA of advanced EGFR-mutant NSCLC patients on first- or second-generation tyrosine kinase inhibitors

The mechanism of acquired resistance to irreversible EGFR tyrosine kinase inhibitor-afatinib in lung adenocarcinoma patients

Two‐month breathing‐based walking improves anxiety, depression, dyspnoea and quality of life in chronic obstructive pulmonary disease: A randomised controlled study

Letter from Taiwan

Dispositional mindfulness, self‐compassion, and compassion from others as moderators between stress and depression in caregivers of patients with lung cancer

Trajectories of caregiver burden and related factors in family caregivers of patients with lung cancer

Suchergebnisse filtern